# China NMPA Drug Inspection - Zhuhai Federal Pharmaceutical Co., Ltd. Zhongshan Branch - Amoxicillin capsules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/zhuhai-federal-pharmaceutical-co-ltd-zhongshan-branch/a7eda3ba-13a0-45a7-9f3d-ce116e1a276a/
Source feed: China

> China NMPA drug inspection for Zhuhai Federal Pharmaceutical Co., Ltd. Zhongshan Branch published June 17, 2021. Drug: Amoxicillin capsules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Zhuhai Federal Pharmaceutical Co., Ltd. Zhongshan Branch
- Publication Date: 2021-06-17
- Drug Name: Amoxicillin capsules
- Inspection Finding: Meets the requirements of drug standards (qualified)
- Action Taken: It does not involve the investigation and handling of substandard drugs.

Company: https://www.globalkeysolutions.net/companies/zhuhai-federal-pharmaceutical-co-ltd-zhongshan-branch/c59a9b54-d48f-4da4-8915-1d5df13879f7/